Researchers showed that in hyperglycemic conditions, metformin increased basolateral intestinal glucose uptake, and its metabolites produced in the gut, through the portal vein reach the liver and reduce hepatic glucose production.
[Proceedings Of The National Academy Of Sciences Of The United States Of America]
